Position in LLY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$3,541,917
+$459,768 QoQ
Shares Held
2,953
-11.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
8.82%
of 13F equity value
Holder Rank
#1,992
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vermillion Wealth Management, Inc. holds $4,445,539 across 14 Drug Manufacturers - General names. LLY ranks #1 (79.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
2,953 | $3,541,917 | |
| 2 | JNJ |
Johnson & Johnson
|
1,032 | $262,096 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,359 | $174,631 | |
| 4 | ABBV |
AbbVie Inc.
|
692 | $174,134 | |
| 5 | AMGN |
Amgen Inc
|
321 | $116,240 | |
| 6 | NVS |
Novartis AG
|
365 | $57,202 | |
| 7 | PFE |
Pfizer Inc
|
1,989 | $47,894 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
500 | $28,810 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,541,917 | 2,953 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $3,082,149 | 3,351 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $3,377,719 | 3,143 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,276,792 | 2,984 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $2,199,833 | 2,822 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $4,390,537 | 5,316 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $4,101,636 | 5,313 | Shares | Sole | 2025-02-21 | |
| No filing history on record for this holder in this stock. | ||||||